Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 718-730
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.718
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.718
Ref. | Year | Type of study | Intervention | Participants | Bacteremia | Cholangitis | Pancreatitis | Septicemia | Mortality |
Brandes et al[23] | 1981 | RCT | Minocycline 300 mg orally | Total: 118 | N/A | Intervention: 0/39 | Intervention: 1/39 | N/A | N/A |
Antibiotics: 39 | Control: 1/79 | Control: 2/79 | |||||||
Control: 79 | |||||||||
Sauter et al[22] | 1990 | RCT | Cefotaxime 2 g IV, 15 min before ERCP | Total: 100 | Intervention: 1/50 | Intervention: 1/50 | Intervention: 0/50 | Intervention: 0/50 | Intervention: 0/50 |
Antibiotics: 50 | Control: 8/50 | Control: 2/50 | Control: 0/50 | Control: 0/50 | Control: 0/50 | ||||
Control: 50 | |||||||||
Niederau et al[21] | 1994 | RCT | Cefotaxime 2 g IV. 15 min before ERCP | Total: 100 | Intervention: 0/50 | Intervention: 0/50 | Intervention: 2/50 | Intervention: 0/50 | Intervention: 0/50 |
Antibiotics: 50 | Control: 4/50 | Control: 4/50 | Control: 3/50 | Control: 8/50 | Control: 0/50 | ||||
Control: 50 | |||||||||
Byl et al[20] | 1995 | RCT | Piperacillin, 4 g IV, 3/d | Total: 68 | Intervention: 0/30 | Intervention: 2/34 | N/A | Intervention: 0/30 | Intervention: 0/34 |
Antibiotics: 34 | Control: 7/32 | Control: 10/34 | Control: 5/32 | Control: 5/34 | |||||
Control: 34 | |||||||||
Finkelstein et al[27] | 1996 | RCT | Cefonicid 1 g IV, 1 h before ERCP | Total: 179 | Intervention: 3/88 | Intervention: 7/88 | N/A | Intervention: 0/88 | Intervention: 0/88 |
Antibiotics: 88 | Control: 2/91 | Control: 2/91 | Control: 0/91 | Control: 0/91 | |||||
Control: 91 | |||||||||
Lorenz et al[24] | 1996 | RCT | Cefuroxime 1.5 g IV, 30 min before ERCP | Total: 99 | Intervention: 3/49 | N/A | N/A | Intervention: 3/49 | Intervention: 0/49 |
Antibiotics: 49 | Control: 8/50 | Control: 5/50 | Control: 0/50 | ||||||
Control: 50 | |||||||||
van den Hazel et al[19] | 1996 | RCT | Piperacillin 4 g IV, 30 min before ERCP | Total: 551 | N/A | Intervention: 12/170 | N/A | Intervention: 2/170 | Intervention: 3/170 |
Antibiotics: 270 | Control: 17/281 | Control: 3/281 | Control: 2/281 | ||||||
Control: 281 | |||||||||
Räty et al[18] | 2001 | RCT | 2g of ceftazidime IV, 30 min before ERCP | Total: 315 | N/A | Intervention: 0/155 | Intervention: 4/155 | N/A | Intervention: 1/155 |
Antibiotics: 155 | Control: 7/160 | Control: 15/160 | Control: 0/160 | ||||||
Control: 160 | |||||||||
Spicak et al[26] | 2002 | RCT | Amoxicillin – clavulanic acid 2.4 g IV | Total 165 | Intervention: 18/73 | Intervention: 4/77 | Intervention: 6/77 | N/A | Intervention: 2/77 |
Antibiotics: 77 | Control: 24/84 | Control: 3/88 | Control: 10/88 | Control: 2/88 | |||||
Control: 88 | |||||||||
Llach et al[25] | 2006 | RCT | Clindamycin 600 mg and gentamicin 80 mg IM, 1 h before ERCP | Total: 62 | Intervention: 2/31 | Intervention: 1/31 | N/A | Intervention: 0/31 | Intervention: 0/31 |
Antibiotics: 31 | Control: 2/30 | Control: 1/31 | Control: 0/30 | Control: 0/30 | |||||
Control: 31 |
- Citation: Merchan MFS, de Moura DTH, de Oliveira GHP, Proença IM, do Monte Junior ES, Ide E, Moll C, Sánchez-Luna SA, Bernardo WM, de Moura EGH. Antibiotic prophylaxis to prevent complications in endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis of randomized controlled trials. World J Gastrointest Endosc 2022; 14(11): 718-730
- URL: https://www.wjgnet.com/1948-5190/full/v14/i11/718.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i11.718